The flavokawains: Uprising medicinal chalcones

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Abu, Nadiah ^a,b   Ho, Wan Y ^c   Yeap, Swee K ^a   Akhtar, M N ^d   Abdullah, Mohd P ^b   Omar, Abdul R ^a   Alitheen, Noorjahan B ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

^d UNIVERSITY MALAYSIA PAHANG   (Malaysia)

Author keywords

Anti cancer; Anti inflammation; Apoptosis; Flavokawain; Kava kava

Indexed keywords

CHALCONE DERIVATIVE; FLAVOKAWAIN A; FLAVOKAWAIN B; FLAVOKAWAIN C; UNCLASSIFIED DRUG;

ANNONACEAE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; APOPTOSIS; CANCER CELL CULTURE; DRUG STRUCTURE; HUMAN; IC 50; LIVER FAILURE; LIVER INJURY; LIVER TOXICITY; MOLECULAR WEIGHT; PIPER METHYSTICUM; REVIEW; STRUCTURE ACTIVITY RELATION; ZINGIBERACEAE;

EID: 84886905724     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-102     Document Type: Review

References (47)

1. Farnsworth N, Akerele O, Bingel A, Soejarto D, Guo Z. Medicinal plants in therapy. Bull World Health Organ 1985, 63:16.
2. Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol 2001, 1:5.
3. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Value Plant Tradit Med Drug Discov 2001, 109:6.
4. Lebot V, Merlin M, Lindstrom L. Kava: the pacific elixir: the definitive guide to its ethnobotany, history, and 1997, Chemistry: Yale University Press.
5. Schwabe K-P. Kava-kava extract, process for the production thereof and use thereof. In. Edited by Patent US, vol. 5296224 1994, United States: Dr. Wilmar Schwabe GmbH & Co.
6. Kuo Y-F, Su Y-Z, Tseng Y-H, Wang S-Y, Wang H-M, Chueh PJ. Flavokawain B, a novel chalcone from alpinia pricei hayata with potent apoptotic activity: involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells. Free Radic Biol Med 2010, 49:13.
7. Zi X, Simoneau AR, Flavokawain A. A novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res 2005, 65(8):7.
8. Szliszka E, Czuba ZP, Mazur B, Paradysz A, Krol W. Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules 2010, 15:18.
9. Dimmock JR, Elias DW, Beazely MA, Kandepu NM. Bioactivities of chalcones. Curr Med Chem 1999, 6:25.
10. Echeverria C, Santibañez JF, Donoso-Tauda O, Escobar CA, Ramirez-Tagle R. Structural antitumoral activity relationships of synthetic chalcones. Int J Mol Sci 2009, 10:11.
11. Bandgara BP, Gawande SS, Bodade RG, Totre JV, Khobragade CN. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorg Med Chem 2010, 18(3):6.
12. Shibata S. Anti-tumorigenic chalcones. Stem Cells 1994, 12:9.
13. Lahtchev KL, Batovska DI, Parushev SP, Ubiyvovkc VM, Sibirny AA. Antifungal activity of chalcones: a mechanistic study using various yeast strains. Eur J Med Chem 2007, 43(10):8.
14. Mojzis J, Varinsk L, Mojzisova G, Kostova I, Mirossay L. Antiangiogenic effects of flavonoids and chalcones. Pharmacol Res 2008, 57:7.
15. Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007, 42:13.
16. Dharmaratne HRW, Nanayakkara NPD, Khan IA. Kavalactones from piper methysticum, and their 13 C NMR spectroscopic analyses. Phytochemistry 2002, 59:429. 10.1016/S0031-9422(01)00443-5, 11830162.
17. Wollenweber E, Rehse C, Dietz VH. The occurrence of aurentiacin and flavokawin B on pityrogramma triangularis Var. Pallida and didymocarpus species. Phytochemistry 1981, 20(5):2.
18. Sauer HV, Hansel R. Kawalaktone und flavonoide aus einer endemischen piper-art Neu guineas. Planta med 1967, 15(4):15.
19. Hseu Y-C, Lee M-S, Wu C-R, Cho H-J, Lin K-Y, Lai G-H, Wang S-Y, Kuo Y-H, Kumar KJS, Yang H-L. The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway. J Agric Food Chem 2012, 60:13.
20. Yang H-L, Chen S-C, Chen C-S, Wang S-Y, Hseu Y-C. Alpinia pricei rhizome extracts induce apoptosis of human carcinoma KB cells via a mitochondria-dependent apoptotic pathway. Food Chem Toxicol 2008, 46(10):6.
21. Fernandes J, Gottlieb O, Xavier L. Chemosystematic implications of flavonoids in aniba riparia. Biochem Syst Ecol 1978, 6(1):3.
22. Seidel V, Bailleul F, Waterman P. (Rel)-1beta,2alpha-di-(2,4-dihydroxy-6-methoxybenzoyl)-3beta, 4alpha-di-(4-methoxyphenyl)-cyclobutane and other flavonoids from the aerial parts of goniothalamus gardneri and goniothalamus thwaitesii. Phytochemistry 2000, 55(5):7.
23. Kwon D-J, Ju SM, Youn GS, Choi SY, Park J. Suppression of iNOS and COX-2 expression by flavokawain a via blockade of NF-κB and AP-1 activation in RAW 264.7 Macrophages. Food Chem Toxicol 2013, 58:7.
24. Tang Y, Simoneau AR, Xie J. Effects of the kava chalcone flavokawain a differ in bladder cancer cells with wild-type versus mutant. Cancer Prev Res 2008, 1:53.
25. Lin C-T, Kumar KJS, Tseng Y-H, Wang Z-J, Pan M-Y, Xiao J-H, Chien S-C, Wang S-Y. Anti-inflammatory activity of flavokawain B from alpinia pricei hayata. J Agric Food Chem 2009, 57:6.
26. Wu D, Nair MG, Dewitt DL. Novel compounds from piper methysticum forst (kava kava) roots and their effect on cyclooxygenase enzyme. J Agric Food Chem 2002, 50:4.
27. Mohamad AS, Akhtar MN, Zakaria ZA, Perimal EK, Khalid S, Mohd PA, Khalid MH, Israf DA, Lajis NH, Sulaiman MR. Antinociceptive activity of a synthetic chalcone, flavokawin B on chemical and thermal models of nociception in mice. Eur J Pharmacol 2010, 647:7.
28. Mohamad AS, Akhtar MN, Khalivulla SI, Perimal EK, Khalid MH, Ong HM, Zareen S, Akira A, Israf DA, Lajis N, et al. Possible participation of nitric oxide/cyclic guanosine monophosphate/protein kinase C/ATP-sensitive K + channels pathway in the systemic antinociception of flavokawin B. Basic Clin Pharmacol Toxicol 2011, 108:6.
29. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 2005, 5:9.
30. Ji T, Lin C, Krill LS, Eskander R, Guo Y, Zi X, Hoang BH: Flavokawain B. a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis. Mol Cancer 2013, 12:55. 10.1186/1476-4598-12-55, 3681603, 23764122.
31. Ahluwalia KP. Assessing oral cancer risk of south-asian immigrants in New york city. Cancer 2005, 104:3.
32. Zhao X, Chao Y-L, Wan Q-B, Chen X-M, Su P, Sun J, Tang Y. Flavokawain B induces apoptosis of human oral adenoid cystic cancer ACC-2 cells via up-regulation of Bim and down-regulation of Bcl-2 expression. Can J Physiol Pharmacol 2011, 89(12):8.
33. Sakai T, Eskander RN, Guo Y, Kim KJ, Mefford J, Hopkins J, Bhatia NN, Zi X, Hoang BH. Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines. J Orthop Res 2011, 30(7):5.
34. Tang Y, Li X, Liu Z, Simoneau AR, Xie J, Zi X. Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth. Int J Cancer 2010, 127:10.
35. Li X, Liu Z, Xu X, Blair CA, Sun Z, Xie J, Lilly MB, Zi X. Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice. PLoS One 2012, 7(2):24.
36. An J, Gao Y, Wang J, Zhu Q, Ma Y, Wu J, Sun J, Tang Y. Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway. Biotechnol Lett 2012, 34:7.
37. Eskander RN, Randall LM, Sakai T, Guo Y, Hoang B, Zi X. Flavokawain B, a novel naturally occuring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. J Obstet Gynaecol Res 2012, 38(8):8.
38. Lin E, Lin W-H, Wang S-Y, Chen C-S, Liao J-W, Chang H-W, Chen S-C, Lin K-Y, Wang L, Yang H-L, et al. Flavokawain B inhibits growth of human squamous carcinoma cells: involvement of apoptosis and cell cycle dysregulation in vitro and in vivo. J Nutr Biochem 2012, 23:10.
39. Feroz SR, Mohamad SB, Bujang N, Malek SNA, Tayyab S. Multispectroscopic and molecular modeling approach to investigate the interaction of flavokawain B with human serum albumin. J Agric Food Chem 2012, 60:9.
40. Li N, Liu J-H, Zhang J, Yu B-Y. Comparative evaluation of cytotoxicity and antioxidative activity of 20 flavonoids. J Agric Food Chem 2008, 56:8.
41. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 2002, 25(1):7.
42. Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G. Linking JNK signaling to NF-κB: a key to survival. J Cell Sci 2004, 117:11.
43. Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 2002, 14:14.
44. Teschke R. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int 2010, 30(9):9.
45. Clouatre D. Kava kava: examining new reports of toxicity. Toxicol Lett 2004, 150(1):11.
46. Zhou P, Gross S, Liu J-H, Yu B-Y, Feng L-L, Nolta J, Sharma V, Piwnica-Worms D, Qiu SX. Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kB and MAPK signaling pathways. FASEB J 2010, 24:11.
47. Teschke R, Qiu S, Lebot V. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis 2011, 43:9.